Discover
PTGX
Protagonist Therapeutics, Inc.
138.31
1 x 124.73
1 x 142.00
bid
ask
+
4.04
3.01%
1 @ 04:00 PM
139.01 +0.70 (0.51%)
| Ytd | 58.36% | |
| 1y | 150.47% |
131.05
day range
139.70
50.48
52 week range
143.29
| Open | 133.80 | Prev Close | 134.27 | Low | 131.05 | High | 139.70 | Mkt Cap | 8.89B |
| Vol | 555.91K | Avg Vol | 716.27K | EPS | -1.81 | P/E | -76.41 | Forward P/E | 28.41 |
| Beta | 1.79 | Short Ratio | 13.55 | Inst. Own | 125.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 114.07 | 200-d Avg | 94.66 | 1yr Est | 125.15 |
| Income Statement | |||
| Total Revenue | 56.37M | ||
| Revenues (USD) | 56.37M | ||
| Gross Profit | 56.37M | ||
| Operating Expenses | 60.02M | ||
| Research and Development Expense | 46.74M | ||
| Selling, General and Administrative Expense | 13.28M | ||
| Operating Income | -3.65M | ||
| Income Tax Expense | -1.50M | ||
| Net Income | 3.78M | ||
| Net Income Common Stock | 3.78M | ||
| Net Income Common Stock (USD) | 3.78M | ||
| Consolidated Income | 3.78M | ||
| Earnings per Basic Share | 0.06 | ||
| Earnings per Basic Share (USD) | 0.06 | ||
| Earnings per Diluted Share | 0.05 | ||
| Earning Before Interest & Taxes (EBIT) | 2.28M | ||
| Earning Before Interest & Taxes (USD) | 2.28M | ||
| Weighted Average Shares | 65.09M | ||
| Weighted Average Shares Diluted | 70.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 193.71M | ||
| Cash and Equivalents (USD) | 193.71M | ||
| Investments | 426.62M | ||
| Investments Current | 354.07M | ||
| Investments Non-Current | 72.55M | ||
| Trade and Non-Trade Receivables | 53.66M | ||
| Current Assets | 613.46M | ||
| Property, Plant & Equipment Net | 11.17M | ||
| Total Assets | 697.46M | ||
| Debt Current | 2.34M | ||
| Total Debt | 9.78M | ||
| Current Liabilities | 34.55M | ||
| Debt Non-Current | 7.44M | ||
| Total Liabilities | 41.99M | ||
| Accumulated Retained Earnings (Deficit) | -466.89M | ||
| Accumulated Other Comprehensive Income | -269.00K | ||
| Shareholders Equity | 655.47M | ||
| Shareholders Equity (USD) | 655.47M | ||
| Assets Non-Current | 84.00M | ||
| Total Debt (USD) | 9.78M | ||
| Deferred Revenue | 6.28M | ||
| Liabilities Non-Current | 7.44M | ||
| Trade and Non-Trade Payables | 8.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 846.00K | ||
| Net Cash Flow from Financing | 23.37M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 65.32M | ||
| Capital Expenditure | -215.00K | ||
| Net Cash Flow from Investing | 90.89M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 91.11M | ||
| Net Cash Flow from Operations | -48.94M | ||
| Share Based Compensation | 14.52M | ||